Anticonvulsant Therapy in Neonate
Journal of the Korean Society of Neonatology
;
: 10-17, 2009.
Article
in Korean
| WPRIM
| ID: wpr-100148
ABSTRACT
The immature neonatal brain is susceptible to the development of seizures. Seizures occur in 1% to 5% of infants during the neonatal period. Neonatal seizures are most commonly associated with serious acute illnesses, such as hypoxic-ischemic encephalopathy, birth trauma, metabolic disturbances, or infections. Thus, newborn infants with seizures are at risk for neonatal death and survivors are at risk for neurologic impairment, developmental delay, and subsequent epilepsy. Experimental data have also raised concerns about the potential adverse effects of the currently used anticonvulsants in neonates on brain development. Therefore, in the management of neonatal seizures, confirmatory diagnosis and optimal, but shorter, duration of anticonvulsant therapy is essential. Nevertheless, there has been substantial progress in understanding the developmental mechanisms that influence seizure generation and responsiveness to anticonvulsants. The currently used therapies have limited efficacy and the treatment of neonatal seizures has not significantly changed in the past several decades, This review includes an overview of current approaches to the treatment of neonatal seizures.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Seizures
/
Brain
/
Survivors
/
Hypoxia-Ischemia, Brain
/
Parturition
/
Epilepsy
/
Anticonvulsants
Limits:
Humans
/
Infant
/
Infant, Newborn
Language:
Korean
Journal:
Journal of the Korean Society of Neonatology
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS